CEO, MD, PhD Weon Kuu Chung 
Hello.
Dementia is a disease that causes suffering to many families around the world, and its
impact is very deep across individuals, families, and society as a whole.
The exact cause of dementia has not yet been identified, and existing treatments are burdening
many patients and their families due to high costs and side effects.
READYCURE was founded in 2021 to solve this serious problem, and has been continuously striving
to create a new breakthrough in the treatment of degenerative neurological diseases.
We are developing an innovative solution called non-drug treatment by combining digital
X-ray and AI.
This technology overcomes the limitations of existing treatments and opens the possibility
of providing safer and more efficient treatment to patients.
In particular, HeLaXON, which we are developing, is a medical device that provides
personalized treatment by combining the multi-mechanism of digital X-ray and AI technology.
We believe that this system can bring about better results in the treatment of degenerative
neurological diseases such as dementia through an innovative approach utilizing low-energy,
pulsed beams.
READYCURE is committed to building a digital X-ray treatment ecosystem, so that patients
with degenerative neurological diseases around the world can receive more efficient and safe treatment.
Our vision is not simply to develop technology, but to substantially improve the quality of
life of patients and their caregivers.
We hope that our innovative treatments can bring new hope to patients and their families
around the world,
and we ask for your continued interest and support.
Thank you.
CEO, MD, PhD Weon Kuu Chung
